Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema
Postȩpy dermatologii i alergologii, 2013-06, Vol.30 (3), p.152-158 [Peer Reviewed Journal]Copyright Termedia Publishing House 2013 ;Copyright © 2013 Termedia 2013 ;ISSN: 1642-395X ;EISSN: 2299-0046 ;DOI: 10.5114/pdia.2013.35616 ;PMID: 24278067
Full text available